Autologous cell therapy for cisplatin-induced acute kidney injury by using non-expanded adipose tissue-derived cells

References

• Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, . Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–7.
   PubMed Web of Science ®Google Scholar
• Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003;9:702–12.
   PubMed Web of Science ®Google Scholar
• Goligorsky MS, Kuo MC, Patschan D, Verhaar MC. Review article. Endothelial progenitor cells in renal disease. Nephrology (Carlton). 2009;14:291–7.
   PubMedGoogle Scholar
• Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R, . Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation. 2001;104:1046–52.
   PubMed Web of Science ®Google Scholar
• Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, . Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360:427–35.
   PubMed Web of Science ®Google Scholar
• Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, . Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004;364:141–8.
   PubMed Web of Science ®Google Scholar
• Fortuin FD, Vale P, Losordo DW, Symes J, DeLaria GA, Tyner JJ, . One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients. Am J Cardiol. 2003;92:436–9.
   PubMed Web of Science ®Google Scholar
• Morishita R, Aoki M, Hashiya N, Makino H, Yamasaki K, Azuma J, . Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension. 2004;44:203–9.
   PubMed Web of Science ®Google Scholar
• Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, . The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation. 2003;107:1359–65.
   PubMed Web of Science ®Google Scholar
• Kastrup J, Jorgensen E, Ruck A, Tagil K, Glogar D, Ruzyllo W, . Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris. A randomized double-blind placebo-controlled study: the Euroinject One trial. J Am Coll Cardiol. 2005;45:982–8.
   PubMed Web of Science ®Google Scholar
• Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, . Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211–28.
   PubMedGoogle Scholar
• Miranville A, Heeschen C, Sengenes C, Curat CA, Busse R, Bouloumie A. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation. 2004;110:349–55.
   PubMed Web of Science ®Google Scholar
• Sanz-Ruiz R, Fernandez-Santos E, Dominguez-Munoa M, Parma R, Villa A, Fernandez L, . Early translation of adipose-derived cell therapy for cardiovascular disease. Cell Transplant. 2009;18:245–54.
   PubMed Web of Science ®Google Scholar
• Iwashima S, Ozaki T, Maruyama S, Saka Y, Kobori M, Omae K, . Novel culture system of mesenchymal stromal cells from human subcutaneous adipose tissue. Stem Cells Dev. 2009;18:533–43.
   PubMed Web of Science ®Google Scholar
• Di Rocco G, Iachininoto MG, Tritarelli A, Straino S, Zacheo A, Germani A, . Myogenic potential of adipose-tissue-derived cells. J Cell Sci. 2006;119:2945–52.
   PubMed Web of Science ®Google Scholar
• Schenke-Layland K, Strem BM, Jordan MC, Deemedio MT, Hedrick MH, Roos KP, . Adipose tissue-derived cells improve cardiac function following myocardial infarction. J Surg Res. 2009;153:217–23.
   PubMed Web of Science ®Google Scholar
• Hoogendoorn RJ, Lu ZF, Kroeze RJ, Bank RA, Wuisman PI, Helder MN. Adipose stem cells for intervertebral disc regeneration: current status and concepts for the future. J Cell Mol Med. 2008;12:2205–16.
   PubMed Web of Science ®Google Scholar
• 18. Urahama Y, Ohsaki Y, Fujita Y, Maruyama S, Yuzawa Y, Matsuo S, et al. Lipid droplet-associated proteins protect renal tubular cells from fatty acid-induced apoptosis. Am J Pathol. 2008;173:1286–94.
   Google Scholar
• Suzuki S, Maruyama S, Sato W, Morita Y, Sato F, Miki Y, . Geranylgeranylacetone ameliorates ischemic acute renal failure via induction of Hsp70. Kidney Int. 2005;67: 2210–20.
   PubMed Web of Science ®Google Scholar
• Ozaki T, Anas C, Maruyama S, Yamamoto T, Yasuda K, Morita Y, . Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure. Nephrol Dial Transplant. 2008;23: 110–9.
   Google Scholar
• Shimizu H, Maruyama S, Yuzawa Y, Kato T, Miki Y, Suzuki S, . Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria. J Am Soc Nephrol. 2003;14:1496–505.
   PubMed Web of Science ®Google Scholar
• Maruyama S, , Cantu E 3rdDemartino C, Vladutiu A, Caldwell PR, Wang CY, . Membranous glomerulonephritis induced in the pig by antibody to angiotensin-converting enzyme: considerations on its relevance to the pathogenesis of human idiopathic membranous glomerulonephritis. J Am Soc Nephrol. 1999;10:2102–8.
   Google Scholar
• Ashjian PH, De Ugarte DA, Katz AJ, Hedrick MH. Lipoplasty: from body contouring to tissue engineering. Aesthet Surg J. 2002;22:121–7.
   PubMedGoogle Scholar
• Yoshimura K, Shigeura T, Matsumoto D, Sato T, Takaki Y, Aiba-Kojima E, . Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Physiol. 2006;208:64–76.
   PubMed Web of Science ®Google Scholar
• Ohnishi S, Ohgushi H, Kitamura S, Nagaya N. Mesenchymal stem cells for the treatment of heart failure. Int J Hematol. 2007;86:17–21.
   PubMed Web of Science ®Google Scholar
• Humphreys BD, Bonventre JV. Mesenchymal stem cells in acute kidney injury. Annu Rev Med. 2008;59:311–25.
   PubMed Web of Science ®Google Scholar
• Nakagami H, Morishita R, Maeda K, Kikuchi Y, Ogihara T, Kaneda Y. Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. J Atheroscler Thromb. 2006;13:77–81.
   PubMed Web of Science ®Google Scholar
• Sgodda M, Aurich H, Kleist S, Aurich I, Konig S, Dollinger MM, . Hepatocyte differentiation of mesenchymal stem cells from rat peritoneal adipose tissue in vitro and in vivo. Exp Cell Res. 2007;313:2875–86.
   PubMed Web of Science ®Google Scholar
• Constantin G, Marconi S, Rossi B, Angiari S, Calderan L, Anghileri E, . Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells. 2009;27:2624–2635.
   PubMed Web of Science ®Google Scholar
• Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG. Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol. 2007;18:2486–96.
   PubMed Web of Science ®Google Scholar
• Chen J, Park HC, Addabbo F, Ni J, Pelger E, Li H, . Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair. Kidney Int. 2008;74:879–89.
   PubMed Web of Science ®Google Scholar
• Nakagawa T. Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease. Am J Physiol Renal Physiol. 2007;292:F1665–72.
   PubMed Web of Science ®Google Scholar
• Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R, . Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med. 1999;5:226–30.
   PubMed Web of Science ®Google Scholar